Trademarkia Logo

Australia

AU$
EXFLUNA
Accepted: In opposition period

Last updated on 22 May 2025

Owner Info

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89

B-1330 Rixensart, BELGIUM

Serial Number

2536721 filed on 17 Feb 2025

Correspondent

Legal Brand Protection Legal and Compliance GSK

79 New Oxford Street,

London WC1A 1DG,

UNITED KINGDOM

EXFLUNA

Classification Information


Class [005]
Pharmaceutical and medicinal preparations and substances; vaccines.

Mark Details


Serial Number

2536721

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

20 Nov 2024

Mark Type

BX

Legal History


Show more

Status DateAction Taken
22nd May 2025Amendment to International Registration Contact Requested
21st Apr 2025Application Accepted correspondence sent
21st Apr 2025IP Right has been Examined
21st Apr 2025IP Right Acceptance Published
15th Apr 2025Status change to Accepted
10th Apr 2025Amendment to International Registration Contact Requested
7th Apr 2025Examination expedited
7th Apr 2025Awaiting examination
3rd Apr 2025IP Right Filed Published
3rd Apr 2025Status change to Published